Information Provided By: 
Fly News Breaks for October 29, 2015
AMGN
Oct 29, 2015 | 05:55 EDT
Piper Jaffray analyst Joshua Schimmer says Amgen last night reported another strong quarter and again raised its guidance for 2015. The company's 2016 outlook "seems to leave plenty of room for upside," Schimmer tells investors in a post-earnings research note. He believes Amgen's pipeline remains underappreciated and calls the stock a core large-cap biotech holding. Schimmer reiterates an Overweight rating on the stock with a $200 price target.
News For AMGN From the Last 2 Days
There are no results for your query AMGN
